Zacks.com on MSN5d
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to KnowVertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day.
Investing in biotech stocks isn't for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is ...
Investors should also note that VRTX has a PEG ratio of 837.5 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected ...
Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.
This was the stock's second consecutive day of losses.
Dimensional Fund Advisors LP Buys 75,045 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Institutional investors own 90.96% of the company’s stock. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever VRTX has been ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback